Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a no-touch device keep watch on patients' hearts and lungs?

NCT ID NCT03750318

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study evaluates Aingeal, a contactless monitoring system that tracks heart rate and breathing, in adult women recovering from gynecological surgery at a Singapore hospital. The goal is to see how accurately the device's alarms match standard nursing checks. If it works well, it could offer a more comfortable way to monitor patients without wires or frequent manual measurements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Aingeal vital signs monitoring system (a contactless device that tracks heart rate and breathing)
What this could lead to
If validated, this contactless monitor could offer a more comfortable way to keep watch on patients' vital signs in hospitals, potentially reducing the need for wires and frequent manual checks.
What could go wrong
This is a small validation study, not a test of treatment effectiveness. The device may not prove accurate enough in real-world settings, and results may not apply beyond the specific group of patients studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

39 people

The number who actually took part.

Started

Jan 2019

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 70 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult female patients, aged 21 years or over * Patients admitted to post-operative gynaecological ward at KKH Women's and Children's Hospital, Singapore * Patients receiving opioid therapy via patient controlled analgesia (PCA) * Patients that are on electronic nursing charting * Patients that are on acute pain service monitoring Exclusion Criteria: * Patients with active, implantable devices (such as a pacemaker or ICD) * Patients with any skin condition or injury affecting the electrode placement site * Patients that are pregnant (Heart Rate detection algorithm has not been designed to reject foetal heart rate)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart rate are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • KK Women's and Children's Hospital

    Singapore, 229899, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.